Learn More
Medchemexpress LLC Cl2a-sn-38 | 1279680-68-0 | 1480.61 | C73H97N11O22 | 50 MG

Supplier: Medchemexpress LLC HY12894650MG
CL2A-SN-38 is a drug-linker conjugate composed of the DNA topoisomerase I inhibitor SN-38 linked via a hydrolyzable CL2A linker, intended for antibody-drug conjugate (ADC) research and development. It releases active SN-38 within tumor cells and the tumor microenvironment, producing bystander antitumor effects.
- Drug-linker conjugate designed for ADC development.
- Releases SN-38 within tumor cells and tumor microenvironment.
- Camptothecin-class topoisomerase I inhibitor mechanism.
- Molecular formula C73H97N11O22; molecular weight 1480.61.
- Soluble in DMSO (100 mg/mL) and in documented in vivo formulations.
- Store at -20°C under nitrogen; in solution -80°C (6 months) or -20°C (1 month).
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.